Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|May 21, 2020
ERα-36 regulates progesterone receptor activity in breast cancerHenri-Philippe Konan, Loay Kassem, Soleilmane Omarjee, et al.
International Journal of Cancer|March 10, 2019
Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohortAmina Amadou, Delphine Praud, Thomas Coudon, et al.
Endocrine-Related Cancer|May 18, 2022
MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cellsRazan Abou Ziki, Romain Teinturier, Yakun Luo, et al.
Breast Cancer Research and Treatment|September 25, 2021
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypesRomain Teinturier, Razan Abou Ziki, Loay Kassem, et al.
Molecular Oncology|June 29, 2014
A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancersNhan T Nguyen, Julie A Vendrell, Coralie Poulard, et al.
EMBO Molecular Medicine|July 17, 2023
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα<sup>+</sup> breast cancerCoralie Poulard, Thuy Ha Pham, Youenn Drouet, et al.
International Journal of Cancer|March 12, 2014
LKB1 when associated with methylatedERα is a marker of bad prognosis in breast cancerKatia Bouchekioua-Bouzaghou, Coralie Poulard, Juliette Rambaud, et al.
Environment International|January 19, 2019
Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohortAurélie Marcelle Nicole Danjou, Thomas Coudon, Delphine Praud, et al.
Cancer Science|March 9, 2026
Targeting PRMTs Creates Vulnerability of DNA Double-Stand Break Repair Pathways, and Potentiates Chemotherapy Efficacy in TNBCCharlène Thiebaut, Sébastien Martinez, Ludivine Pruvost, et al.
Pageof 6